,i #aahth ,,congress #b;d ,session ,h4 ,r4 #ajjej ,,in ,,the ,,house ,,of ,,representatives ,october #be1 #bjbd,ms4 ,maloy 7for herself1 ,mr4 ,krishnamoorthi1 and ,mrs4 ,harshbarger7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on ,ways and ,means1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to require the ,secretary of ,health and ,human ,services to conduct a study on pharmacy benefit manager audit practices4 #a4 ,study on pharmacy benefit manager audit practices ,not later than #a year after the date of the enactment of this ,act1 the ,secretary of ,health and ,human ,services shall1 taking into account input from independent pharmacists1 pharmacy benefit managers1 health care providers1 and appropriate agencies1 conduct a study and submit to ,congress a report on audit practices of pharmacy benefit managers with respect to drugs dispensed under the ,medicare and ,medicaid programs1 group health plans1 and group or individual health insurance coverage4 ,such report shall include the following3 7#a7 ,an assessment of the financial and operations impacts of current pharmacy benefit manager audit requirements on independent and other retail community pharmacies4 7#b7 ,an evaluation of the appropriateness of current purchase documentation timeframes in relation to medication shelf lives1 including with respect to medications that have a shelf life approved by the ,food and ,drug ,administration of #b years or more4 7#c7 ,an evaluation of the transparency of current and historic pharmacy benefit manager audit requirements and recommendations on how to make such requirements more transparent and less burdensome on pharmacists4 7#d7 ,best practices for pharmacy benefit manager audit processes that ensure fairness and ease burdens on pharmacists without compromising the integrity of the audit4